ViroPharma Announces Publication of Cinryze (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine

- Publication Describes Phase 3 Studies of Cinryze™ (C1
Esterase Inhibitor [Human]) in Preventing and Treating Attacks of
HAE -
EXTON, Pa., Aug. 5 /PRNewswire-FirstCall/ -- ViroPharma
Incorporated (Nasdaq: VPHM) today announced that data from...